Neurologic Complications in Peripheral Regional Anesthesia - An Evaluation Based on a Standardized Protocol
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00445016|
Recruitment Status : Unknown
Verified May 2008 by BG Unfallklinik.
Recruitment status was: Active, not recruiting
First Posted : March 8, 2007
Last Update Posted : May 9, 2008
|Condition or disease||Intervention/treatment|
|Anesthesia, Conduction Nerve Block Adverse Effects||Procedure: peripheral regional anesthesia|
Neurologic complications as an adverse effect occur in all types of regional anesthesia. Reviewing the literature, the incidence spreads from 0.02 up to 3 percent. The incidence remains unclear because of different types of definitions, too. In this study, we evaluate all patients receiving peripheral regional anesthesia 24 hours after block performance according to a standardized study protocol. In case of any conspicuousness concerning motoric or sensory function or pain, the patient will be evaluated again after 48 hours. Further on, in case of neurologic dysfunction, periods of investigation will be after 3 days, 1 week, 2 weeks, 1 month, 3 months, 6 months and 1 year. This study includes the definition for nerve damage concerning motoric and sensory neural function and pain.
The patients will be recruited among all patients from our hospital receiving continuous peripheral regional anesthesia.
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Neurologic Complications in Peripheral Regional Anesthesia - A Clinical Follow Up Study to Evaluate the Incidence of Neurologic Complications Defined According to a Standardized Protocol Considering Motoric and Sensory Function and Pain|
|Study Start Date :||May 2008|
|Estimated Study Completion Date :||December 2008|
- Procedure: peripheral regional anesthesia
evaluation and description of adverse effects
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00445016
|Murnau, Bayern, Germany, 82418|
|Study Chair:||Johannes Buettner, MD||BG Unfallklinik Murnau|